Cargando…

Knockdown of Peripheral Myelin Protein 22 Inhibits the Progression of Chronic Myeloid Leukemia

We aimed to explore the underlying mechanism of peripheral myelin protein 22 (PMP22) in the development of chronic myeloid leukemia (CML). The level of PMP22 expression in CD34(+) cells isolated from CML patients’ bone marrow samples (BMMCs) and peripheral blood samples (PBMCs) was determined by RT-...

Descripción completa

Detalles Bibliográficos
Autores principales:	Liu, Hui, Cao, Hui-qin, Ta, Jin-bao, Zhang, Wen, Liu, Yu-hong
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Cognizant Communication Corporation 2015
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7842503/ https://www.ncbi.nlm.nih.gov/pubmed/26629937 http://dx.doi.org/10.3727/096504015X14410238486603

Ejemplares similares

Peripheral myelin protein 22 alters membrane architecture
por: Mittendorf, Kathleen F., et al.
Publicado: (2017)

Knockdown of ADORA2A antisense RNA 1 inhibits cell proliferation and enhances imatinib sensitivity in chronic myeloid leukemia
por: Liu, Yabo, et al.
Publicado: (2022)

Expression profile of CREB knockdown in myeloid leukemia cells
por: Pellegrini, Matteo, et al.
Publicado: (2008)

Fumarate hydratase deficiency induces chronic myeloid leukemia progression
por: Li, Shan, et al.
Publicado: (2019)

Major progress in understanding progression in chronic myeloid leukemia
por: Radich, Jerry
Publicado: (2015)

A Novel Missense Mutation in Peripheral Myelin Protein-22 Causes Charcot-Marie-Tooth Disease
por: Li, Li-Xi, et al.
Publicado: (2017)

Peripheral myelin protein-22 (PMP22) modulates alpha 6 integrin expression in the human endometrium
por: Rao, Rajiv G, et al.
Publicado: (2011)

Peripheral myelin protein 22 preferentially partitions into ordered phase membrane domains
por: Marinko, Justin T., et al.
Publicado: (2020)

Peripheral neuropathy associated with imatinib therapy for chronic myeloid leukemia
por: Kavanagh, Simon, et al.
Publicado: (2018)

The Progression of Chronic Myeloid Leukemia to Myeloid Sarcoma: A Systematic Review
por: Arzoun, Hadia, et al.
Publicado: (2022)

Elevated Th22 Cells Correlated with Th17 Cells in Peripheral Blood of Patients with Acute Myeloid Leukemia
por: Yu, Shuang, et al.
Publicado: (2014)

Chronic myeloid leukemia blast crisis presented with AML of t(9;22) and t(3;14) mimicking acute lymphocytic leukemia
por: Liu, Keyu, et al.
Publicado: (2019)

Side effects and medication adherence of tyrosine kinase inhibitors for patients with chronic myeloid leukemia in Taiwan
por: Tsai, Yu-Fen, et al.
Publicado: (2018)

SOX30 methylation correlates with disease progression in patients with chronic myeloid leukemia
por: Zhang, Ting-Juan, et al.
Publicado: (2019)

Knockdown of ribonucleotide reductase regulatory subunit M2 increases the drug sensitivity of chronic myeloid leukemia to imatinib-based therapy
por: Liu, Chunshui, et al.
Publicado: (2019)

Improved neurite outgrowth on central nervous system myelin substrate by siRNA-mediated knockdown of Nogo receptor
por: Ding, Sheng-Hao, et al.
Publicado: (2016)

TCF7 knockdown inhibits the imatinib resistance of chronic myeloid leukemia K562/G01 cells by neutralizing the Wnt/β-catenin/TCF7/ABC transporter signaling axis
por: Zhang, Hui, et al.
Publicado: (2021)

Complex Variant t(9;22) Chromosome Translocations in Five Cases of Chronic Myeloid Leukemia
por: Valencia, Ana, et al.
Publicado: (2009)

B-Cell Chronic Lymphocytic Leukemia with 11q22.3 Rearrangement in Patient with Chronic Myeloid Leukemia Treated with Imatinib
por: Lewandowski, Krzysztof, et al.
Publicado: (2016)

LncRNA MVIH knockdown inhibits the malignancy progression through downregulating miR-505 mediated HMGB1 and CCNE2 in acute myeloid leukemia
por: Ke, Shandong, et al.
Publicado: (2019)

Knockdown of MEF2D inhibits the development and progression of B-cell acute lymphoblastic leukemia
por: Chang, Ning, et al.
Publicado: (2023)

Characterization of a novel peripheral nervous system myelin protein (PMP-22/SR13)
Publicado: (1992)

UBE2T knockdown inhibits gastric cancer progression
por: Luo, Changjiang, et al.
Publicado: (2017)

Chronic myeloid leukemia
por: Hantschel, Oliver
Publicado: (2019)

Chronic myeloid leukemia
por: Sauβele, Susanne
Publicado: (2018)

Pyrvinium selectively targets blast phase-chronic myeloid leukemia through inhibition of mitochondrial respiration
por: Xiang, Wei, et al.
Publicado: (2015)

Combination Therapies in Chronic Myeloid Leukemia for Potential Treatment-Free Remission: Focus on Leukemia Stem Cells and Immune Modulation
por: Mu, Hui, et al.
Publicado: (2021)

Knockdown of hsa_circ_0008922 inhibits the progression of glioma
por: Xue, Chunhong, et al.
Publicado: (2022)

Myeloid leukemia with t(7;21)(p22;q22) and 5q deletion
por: PANAGOPOULOS, IOANNIS, et al.
Publicado: (2013)

Targeted Knockdown of IQGAP1 Inhibits the Progression of Esophageal Squamous Cell Carcinoma In Vitro and In Vivo
por: Wang, Xiao-Xia, et al.
Publicado: (2014)

Notch2 inhibits proliferation of chronic myeloid leukemia cells
por: YANG, ZESONG, et al.
Publicado: (2013)

How T118M peripheral myelin protein 22 predisposes humans to Charcot–Marie–Tooth disease
por: Stefanski, Katherine M., et al.
Publicado: (2022)

The structure of the hematopoietic system can explain chronic myeloid leukemia progression
por: Pérez-Jiménez, Mario, et al.
Publicado: (2023)

Correction: UBE2T knockdown inhibits gastric cancer progression
por: Luo, Changjiang, et al.
Publicado: (2023)

Chronic myeloid leukemia versus acute myeloid leukemia in patients with retinoblastoma
por: Leahey, Ann-Marie, et al.
Publicado: (2021)

Presence of the myelin-associated glycoprotein correlates with alterations in the periodicity of peripheral myelin
Publicado: (1982)

Knockdown lncRNA DLEU1 Inhibits Gliomas Progression and Promotes Temozolomide Chemosensitivity by Regulating Autophagy
por: Lv, Qiao-Li, et al.
Publicado: (2020)

Acute Basophilic Leukemia Arising from Chronic Myeloid Leukemia with +8, I(17q)(q10) and der(22)t(9;22) After Imatinib Therapy
por: Shan, Peng, et al.
Publicado: (2023)

Systemic mastocytosis associated with t(8;21)(q22;q22) acute myeloid leukemia
por: Pullarkat, Sheeja T., et al.
Publicado: (2009)

HNRNPH1 Is a Novel Regulator Of Cellular Proliferation and Disease Progression in Chronic Myeloid Leukemia
por: Liu, Menghan, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_p6o5oihkbbnf6ab671lre2jmr5